Inventor · disambiguated record
Yuanxi Zhou
Also filed as: ZHOU YUANXI
40 granted patents·19 pending applications·398 citations·filing 2000–2022
97Inventor score
Top patents by PatentIndex Score
59 records- 0194US9120781B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2011·Granted Sep 1, 2015·29 cites·6 claims
- 0294US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 0394US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 0494US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 0593US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 0693US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 0793US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 0890US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 0989US8778967B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2012·Granted Jul 15, 2014·18 cites·20 claims
- 1084US8377968B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2009·Granted Feb 19, 2013·7 cites·2 claims
- 1182US9243020B2Selective glycosidase inhibitors and uses thereofKAUL RAMESH·Filed 2011·Granted Jan 26, 2016·7 cites·45 claims
- 1282US8933040B2Selective glycosidase inhibitors and uses thereofCOBURN CRAIG A·Filed 2011·Granted Jan 13, 2015·8 cites·22 claims
- 1381US9096522B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2013·Granted Aug 4, 2015·5 cites·11 claims
- 1481US8927507B2Selective glycosidase inhibitors and uses thereofMCEACHERN ERNEST J·Filed 2012·Granted Jan 6, 2015·9 cites·21 claims
- 1581US8569344B2N-piperidinyl acetamide derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2012·Granted Oct 29, 2013·5 cites·5 claims
- 1678US9522883B2Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Granted Dec 20, 2016·2 cites·9 claims
- 1776US7396840B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Jul 8, 2008·1 cites·9 claims
- 1875US10322111B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2016·Granted Jun 18, 2019·1 cites·13 claims
- 1975US7312234B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Dec 25, 2007·7 cites·6 claims
- 2074US9796680B2Glucocerebrosidase modulators and uses thereofALECTOS THERAPEUTICS INC·Filed 2014·Granted Oct 24, 2017·2 cites·14 claims
- 2173US7629337B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Dec 8, 2009·1 cites·9 claims
- 2272US9409924B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Aug 9, 2016·2 cites·21 claims
- 2371US9199949B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Dec 1, 2015·1 cites·7 claims
- 2470US8901087B2Selective glycosidase inhibitors and uses thereofCHANG JIANG·Filed 2011·Granted Dec 2, 2014·1 cites·43 claims
- 2569US7084155B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Aug 1, 2006·3 cites·15 claims
- 2667US9126957B2Selective glycosidase inhibitors and uses thereofSELNICK HAROLD G·Filed 2012·Granted Sep 8, 2015·1 cites·19 claims
- 2767US7183273B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Feb 27, 2007·2 cites·10 claims
- 2867US2020000774A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2019·Application pending·0 cites
- 2966US7491735B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Feb 17, 2009·3 cites·6 claims
- 3063US2015038509A1Chemokine Receptor Binding Heterocyclic Compounds With Enhanced EfficacyGENZYME CORP·Filed 2014·Application pending·0 cites
- 3162US7807694B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Oct 5, 2010·0 cites·4 claims
- 3262US2008167341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2008·Application pending·0 cites
- 3361US2010105915A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 3459US2022409589A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2022·Application pending·0 cites
- 3557US2015299122A1Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3657US2008090846A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY·Filed 2007·Application pending·0 cites
- 3754US2023174486A1Non-lysosomal glucosylceramidase inhibitors and uses thereofALECTOS THERAPEUTICS LNC·Filed 2021·Application pending·0 cites
- 3853US9701693B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Jul 11, 2017·0 cites·7 claims
- 3952US10081601B2Glucocerebrosidase modulators and uses thereofALECTOS THERAPEUTICS INC·Filed 2017·Granted Sep 25, 2018·0 cites·11 claims
- 4052US7790747B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2006·Granted Sep 7, 2010·0 cites·14 claims
- 4152US2017107180A1Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4251US9809537B2Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Granted Nov 7, 2017·0 cites·6 claims
- 4351US2009298834A14-(aminomethyl)cyclohexanamine derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2009·Application pending·0 cites
- 4450US2022213058A1Non-lysosomal glucosylceramidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4549US2016175315A1N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 4649US2003220341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyFiled 2002·Application pending·0 cites
- 4748US2008227823A1Amide derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2008·Application pending·0 cites
- 4845US10913733B2Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Feb 9, 2021·0 cites·21 claims
- 4944US9815861B2Selective glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2015·Granted Nov 14, 2017·0 cites·23 claims
- 5044US9695197B2Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Granted Jul 4, 2017·0 cites·4 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yuanxi Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →